Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: lung and prostate cancers
This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. These analyses...
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers
In this paper, experts in their fields provide perspectives on the current state of play and future directions for screening and surveillance for melanoma, Lynch syndrome, and liver, lung and prostate cancers in Australia.
This report paints the clearest picture yet of the true burden of lung cancer in Australia, now and over the next decade. It hones in on the confronting challenges facing those living with lung cancer and outlines solutions to improve outcomes that are currently far...
The Standards of Service Provision for Lung Cancer Patients in New Zealand have been developed to ensure that people with lung cancer receive the best possible care, regardless of where they live. The standards include requirements for investigation, diagnosis, treatment and supportive care. They also...